Coherus BioSciences (CHRS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist

1.630
+0.020+1.25%

Trading Dec 11 15:08 ET

187.81MMarket Cap-18.11P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Biosimilars Market Industry Trends and Global Forecasts to 2035, Featuring Amgen, BIOCAD, Biocon, Celltrion, Coherus BioSciences, Eli Lilly, Fresenius Kabi, Pfizer, Sandoz and Teva Pharmaceuticals - ResearchAndMarkets.com
BusinesswireDec 10 09:48 ET
TD Cowen Reaffirms Their Buy Rating on Coherus Biosciences (CHRS)
TipRanksDec 5 11:53 ET · Ratings
Coherus BioSciences Price Target Raised to $6.00/Share From $4.00 by Baird
Dow JonesDec 5 08:23 ET · Ratings
Coherus BioSciences Is Maintained at Outperform by Baird
Dow JonesDec 5 08:23 ET · Ratings
Coherus Biosciences Announces Board Member Resignation
TipRanksDec 4 16:50 ET
Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Boosted 137% But Its Business Prospects Need A Lift Too
Simply Wall StDec 4 07:21 ET

Comments

Jaguar8

Dec 3 16:27

🟢Watchlist Wednesday, December 4. NFA. Check on my previous watchlist. Those without ✅ means they can have delayed market reaction.

Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...